Increasing Incidence Rate of Cataract to Augment the Ophthalmic Femtosecond Lasers Market Growth

Femtosecond laser is an infrared, ultrafast, ultrashort pulse laser with a wavelength of 1053 nm. Femtosecond lasers produce photoionization/photodisruption of the optically transparent tissue such as cornea. These layers have a wide range of applications in ophthalmic surgery. Ophthalmic femtosecond lasers are used to correct myopia (a common vision condition). The procedure involves making two lamellar cuts in the cornea that intersect in the periphery, thus creating a lenticule that is removed. Moreover, ophthalmic femtosecond laser allows doctor to select the flap thickness and flap diameter, as well as cutting angle, diameter, and position of the hinge.

The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/385

Market Dynamics:

Increasing incidence rate of cataract and growing geriatric population worldwide is expected to propel the growth of the ophthalmic femtosecond lasers market. The leading causes of vision impairment and blindness are refractive errors and cataracts. For instance, worldwide, at least 1 billion people have a near or distance vision impairment that could have been prevented or has yet to be addressed, according to the World Health Organization (WHO).

Moreover, increasing prevalence of ophthalmic disorders, increasing regulatory approvals for ophthalmic lasers, and technological advancements are expected to aid in the growth of the ophthalmic femtosecond lasers market. For instance, in March 2018, Alcon received 510(k) clearance from the U.S. FDA (Food and Drug Administration) for LenSx Laser (a femtosecond laser) for the indication of intracorneal rings and pockets for presbyopia-correcting inlays.

Increasing prevalence of chronic diseases such as diabetes, especially in North America, and initiatives to control visual impairment are also expected to fuel the growth of the ophthalmic femtosecond lasers market. For instance, according to American Diabetes Association, in 2018, around 34.2 million Americans, or 10.5% of the population, had diabetes. However, high cost of equipment and therapy is expected to restrain the market growth.

Major players in the market are adopting various strategies, such as product launch, merger and acquisition, etc. to enhance their market share. For instance, in 2019, SCHWIND eye-tech-solutions introduced Schwind ATOS, a new femtosecond laser with smartsight procedure.

Moreover, in 2018, LENSAR announced the acquisition of Precision Eye Services. This acquisition consolidates the Company’s customer base for greater optimization, efficiency, and speed to market.

Major Players In The Industry Are: IMRA America, Inc., Newport Corporation, Abbott Medical Optics, Alcon, Bausch & Lomb, Carl Zeiss Meditec, and Ziemer Ophthalmic Systems.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Buy This Research Study Report With Flat US $2000 Off https://www.coherentmarketinsights.com/promo/buynow/385

More Related Report:

Hemorrhoid Treatment Devices Market - https://www.medgadget.com/2021/07/hemorrhoid-treatment-devices-market-increasing-incidence-and-prevalence-of-hemorrhoid-disease-in-the-u-s-is-expected-to-drive-the-market-growth.html

Janus Kinase Inhibitor Market - https://www.medgadget.com/2021/07/janus-kinase-inhibitor-market-jak-inhibitors-are-increasingly-preferred-for-industrial-research-due-to-their-critical-role-in-immune-response-signaling-to-the-significant-growth.html

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.